3.49
price down icon4.12%   -0.15
pre-market  プレマーケット:  3.21   -0.28   -8.02%
loading
前日終値:
$3.64
開ける:
$3.62
24時間の取引高:
950.25K
Relative Volume:
12.94
時価総額:
$2.57M
収益:
$4.79M
当期純損益:
$-13.42M
株価収益率:
-1.312
EPS:
-2.66
ネットキャッシュフロー:
$-10.30M
1週間 パフォーマンス:
+3.97%
1か月 パフォーマンス:
+10.09%
6か月 パフォーマンス:
-57.44%
1年 パフォーマンス:
-82.33%
1日の値動き範囲:
Value
$3.21
$3.7799
1週間の範囲:
Value
$3.0853
$4.02
52週間の値動き範囲:
Value
$2.96
$29.43

Qualigen Therapeutics Inc Stock (QLGN) Company Profile

Name
名前
Qualigen Therapeutics Inc
Name
セクター
Healthcare (1165)
Name
電話
(760) 918-9165
Name
住所
2042 CORTE DEL NOGAL, CALIFORNIA
Name
職員
4
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
QLGN's Discussions on Twitter

QLGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
QLGN
Qualigen Therapeutics Inc
3.49 2.57M 4.79M -13.42M -10.30M -2.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Qualigen Therapeutics Inc (QLGN) 最新ニュース

pulisher
Apr 01, 2025

Qualigen Therapeutics Delays Yearly Financial Report - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Qualigen Therapeutics to acquire Marizyme in strategic move - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Medical Breakthrough: Qualigen's Strategic Move to Transform $10B Heart Surgery Market - Stock Titan

Apr 01, 2025
pulisher
Feb 16, 2025

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Short Interest Up 49.4% in January - Defense World

Feb 16, 2025
pulisher
Jan 28, 2025

Qualigen to invest in NanoSynex, stock tumbles 21% - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

Qualigen Therapeutics Invests in NanoSynex’s Growth - TipRanks

Jan 28, 2025
pulisher
Jan 28, 2025

Qualigen to participate in next funding round for NanoSynex - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

This Breakthrough Could Cut Antibiotic Testing Time in HalfQualigen's Strategic Investment - StockTitan

Jan 28, 2025
pulisher
Jan 17, 2025

Microbiomes Market to Grow by USD 1.13 Billion (2024-2028), Driven by Rising Disease Prevalence; AI Impact on Market TrendsTechnavio - The Malaysian Reserve

Jan 17, 2025
pulisher
Jan 10, 2025

Qualigen Therapeutics (NASDAQ:QLGN) Stock Price Down 5.2% – Time to Sell? - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Qualigen Therapeutics (NASDAQ:QLGN) Shares Down 5.2% – Here’s Why - Defense World

Jan 10, 2025
pulisher
Dec 19, 2024

Qualigen Therapeutics (NASDAQ:QLGN) Trading Down 7.8% – Time to Sell? - Defense World

Dec 19, 2024
pulisher
Dec 10, 2024

SEC Form S-1 filed by Qualigen Therapeutics Inc. - Quantisnow

Dec 10, 2024
pulisher
Dec 06, 2024

Qualigen Therapeutics regains compliance with Nasdaq's listing requirements - MSN

Dec 06, 2024
pulisher
Dec 05, 2024

Qualigen Therapeutics regains Nasdaq compliance By Investing.com - Investing.com UK

Dec 05, 2024
pulisher
Dec 05, 2024

Qualigen Therapeutics Announces Regained Compliance with - GlobeNewswire

Dec 05, 2024
pulisher
Dec 05, 2024

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement - Yahoo Finance

Dec 05, 2024
pulisher
Nov 25, 2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - The Manila Times

Nov 25, 2024
pulisher
Nov 25, 2024

Univest Securities, LLC Announces Successful Closing of - GlobeNewswire

Nov 25, 2024
pulisher
Nov 22, 2024

Qualigen Therapeutics, Inc. announced that it expects to receive $5.1 million in funding - Marketscreener.com

Nov 22, 2024
pulisher
Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding By Investing.com - Investing.com South Africa

Nov 19, 2024
pulisher
Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - The Manila Times

Nov 19, 2024
pulisher
Nov 18, 2024

Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World

Nov 18, 2024
pulisher
Nov 15, 2024

Qualigen Therapeutics Inc (QLGN) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Qualigen Therapeutics appoints new board member - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Qualigen Therapeutics appoints new board member By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 13, 2024

Qualigen Therapeutics Appoints Graydon Bensler to Board - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

QLGN Stock Touches 52-Week Low at $3.71 Amid Market Challenges - Investing.com Canada

Nov 13, 2024
pulisher
Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split By Investing.com - Investing.com UK

Nov 11, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Enterprise Value : €4.58 Mil (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Operating Cash Flow per Sh - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Shares Outstanding (EOP) : 0.19 Mil (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Long-Term Debt & Capital L - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) EV-to-Revenue : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Cash Flow from Financing : €1.51 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Appointment of Amy Broidrick as Executive Vice President and Chief Strategy Officer - Marketscreener.com

Nov 06, 2024
pulisher
Nov 05, 2024

QLGN stock touches 52-week high at $5.05 amid market fluctuations - Investing.com

Nov 05, 2024
pulisher
Nov 03, 2024

Qualigen Therapeutics Stock to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN) - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewswire

Nov 01, 2024
pulisher
Oct 30, 2024

Would I Buy Qualigen Therapeutics Inc (NASDAQ: QLGN) Stock At Any Time In The Future? - Stocks Register

Oct 30, 2024
pulisher
Oct 30, 2024

Qualigen Therapeutics announces results of annual stockholder meeting By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 29, 2024

Qualigen Therapeutics announces results of annual stockholder meeting - Investing.com India

Oct 29, 2024
pulisher
Oct 26, 2024

Qualigen Therapeutics (STU:7R9) Enterprise Value : €4.47 Mil (As of Oct. 26, 2024) - GuruFocus.com

Oct 26, 2024
pulisher
Oct 25, 2024

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - openPR

Oct 25, 2024
pulisher
Oct 25, 2024

QLGN stock touches 52-week low at $0.11 amid market challenges - Investing.com India

Oct 25, 2024

Qualigen Therapeutics Inc (QLGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):